Pulmatrix Inc (PULM) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.91
• Market Cap: $11.72M
• EPS: $-1.71
• 52-Week High: $9.37
• 52-Week Low: $2.15

Market Sentiment

Pulmatrix Inc currently has a Bearish sentiment score of -0.53.

About Pulmatrix Inc

Pulmatrix, Inc. is a clinical-stage biopharmaceutical company headquartered in Lexington, Massachusetts, dedicated to the discovery and development of innovative inhaled therapies for respiratory diseases and other serious conditions characterized by unmet medical needs. By harnessing its proprietary technologies and extensive expertise in inhalation drug delivery, Pulmatrix is actively advancing a pipeline of transformative treatments that aim to significantly enhance patient outcomes and ov...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Pulmatrix Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PULM pay dividends?

Pulmatrix Inc (PULM) does not currently pay a regular dividend.

What is PULM's market cap?

Pulmatrix Inc (PULM) has a market capitalization of $11.72M with a current stock price of $2.91.